UK MHRA okays Marksans Pharma anti-diarrhoea drug Loperamide
New Delhi: Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Loperamide 2mg Hard Capsules.Loperamide Capsules is an anti-diarrhoea medication.Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located at Goa, India.Read also: Marksans Pharma...
New Delhi: Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Loperamide 2mg Hard Capsules.
Loperamide Capsules is an anti-diarrhoea medication.
Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located at Goa, India.
Read also: Marksans Pharma gets USFDA nod for Acetaminophen ER Tablets
Marksans Pharma, headquartered at Mumbai (India) is a global pharmaceutical company.
The company's key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology, among others.
Read also: Marksans Pharma appoints Dr Meena Rani Surana as Independent Woman Directo
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd